Garvan Institute of Medical Research
A Translational Strategy & Portfolio Analyst at Garvan Institute of Medical Research evaluates scientific assets through commercial, clinical, and competitive lenses to inform investment decisions and translation pathways. The role involves assessing target indications, developing competitive intelligence, and creating strategic insights to guide portfolio strategy.
Headquarters
Darlinghurst, New South Wales, Australia
Company Size
501-1000 employees
Founded
1963
N/A
Left or right arm? New research reveals why vaccination site matters for immune response
Apr 28, 2025
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium
Nov 18, 2025
AI tool identifies five distinct cancer cell groups within individual tumors
Jun 24, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Garvan Institute of Medical Research.
8% above the average for this role
Historic $25m investment aims to halve breast cancer deaths
Aug 6, 2025
Portfolio Strategy Analyst III
Daikin Applied
Clinical Director (Principal Scientist), Translational Medicine, Immunology
MSD
Translational Technician - Generative Biology Institute
Ellison Institute of Technology
Pipeline & Portfolio Market Planning Intern
Corcept Therapeutics
Translational Scientist - Generative Biology Institute
Ellison Institute of Technology
Senior Scientific Portfolio Manager (Translational Therapeutics)
The Michael J. Fox Foundation for Parkinson's Research